Cargando…
Host protein glycosylation in nucleic acid vaccines as a potential hurdle in vaccine design for nonviral pathogens
Nucleic acid vaccines introduce the genetic materials encoding antigenic proteins into host cells. If these proteins are directed into the secretory pathway with a signal/leader sequence, they will be exposed to the host’s glycosylation machinery, and, if their amino acid sequences contain consensus...
Autores principales: | Ozdilek, Ahmet, Paschall, Amy V., Dookwah, Michelle, Tiemeyer, Michael, Avci, Fikri Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6983373/ https://www.ncbi.nlm.nih.gov/pubmed/31907319 http://dx.doi.org/10.1073/pnas.1916131117 |
Ejemplares similares
-
Modulation of immunosuppressant drug treatment to improve SARS-CoV-2 vaccine efficacy in mice
por: Paschall, Amy V., et al.
Publicado: (2022) -
Glycopeptide epitope facilitates HIV-1 envelope specific humoral immune responses by eliciting T cell help
por: Sun, Lina, et al.
Publicado: (2020) -
Harnessing galactose oxidase in the development of a chemoenzymatic platform for glycoconjugate vaccine design
por: Duke, Jeremy A., et al.
Publicado: (2021) -
Nonviral Approaches for Neuronal Delivery of Nucleic Acids
por: Bergen, Jamie M., et al.
Publicado: (2007) -
Synaptic roles for phosphomannomutase type 2 in a new Drosophila congenital disorder of glycosylation disease model
por: Parkinson, William M., et al.
Publicado: (2016)